Development of a novel radioimmunoassay to detect autoantibodies to amyloid beta peptides in the presence of a cross-reactive therapeutic antibody.
暂无分享,去创建一个
Ronald R Bowsher | R. Dean | R. Bowsher | Robert A Dean | R. Konrad | Robert J Konrad | John H Sloan | Bradley J Ackermann | Mark O'Dell | J. Sloan | M. O'Dell | B. Ackermann
[1] Deqin Sun,et al. Detection of antibodies against therapeutic proteins in the presence of residual therapeutic protein using a solid-phase extraction with acid dissociation (SPEAD) sample treatment prior to ELISA. , 2007, Regulatory toxicology and pharmacology : RTP.
[2] T. Iwatsubo,et al. Aβ Immunotherapy: Intracerebral Sequestration of Aβ by an Anti-Aβ Monoclonal Antibody 266 with High Affinity to Soluble Aβ , 2009, The Journal of Neuroscience.
[3] B. Ackermann,et al. Comparison of assay formats for drug-tolerant immunogenicity testing. , 2010, Bioanalysis.
[4] R. Motter,et al. Epitope and isotype specificities of antibodies to β-amyloid peptide for protection against Alzheimer's disease-like neuropathology , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[5] J. Hazes,et al. The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. , 2000, Arthritis and rheumatism.
[6] A. Solomon,et al. Diagnostic and Therapeutic Potential of Amyloid-Reactive IgG Antibodies Contained in Human Sera1 , 2006, The Journal of Immunology.
[7] E. Novellino,et al. An N-glucosylated peptide detecting disease-specific autoantibodies, biomarkers of multiple sclerosis. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[8] George Scott,et al. Recommendations for the design and optimization of immunoassays used in the detection of host antibodies against biotechnology products. , 2004, Journal of immunological methods.
[9] B. Hyman,et al. Autoantibodies to amyloid‐β and Alzheimer's disease , 2001, Annals of neurology.
[10] Jana S Chain,et al. An Affinity Capture Elution (ACE) assay for detection of anti-drug antibody to monoclonal antibody therapeutics in the presence of high levels of drug. , 2007, Journal of immunological methods.
[11] Eugen Koren,et al. An acid dissociation bridging ELISA for detection of antibodies directed against therapeutic proteins in the presence of antigen. , 2005, Journal of immunological methods.
[12] M. Weksler,et al. Do age-associated changes in ‘physiologic’ autoantibodies contribute to infection, atherosclerosis, and Alzheimer's disease? , 2002, Experimental Gerontology.
[13] N. Relkin,et al. Patients with Alzheimer disease have lower levels of serum anti-amyloid peptide antibodies than healthy elderly individuals , 2002, Experimental Gerontology.
[14] Bin Yuan,et al. Insights into the mechanisms of action of anti‐Aβ antibodies in Alzheimer's disease mouse models , 2006 .
[15] David J. Cummins,et al. Peripheral anti-Aβ antibody alters CNS and plasma Aβ clearance and decreases brain Aβ burden in a mouse model of Alzheimer's disease , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[16] J. Malter,et al. Anti‐Aβ: The good, the bad, and the unforeseen , 2004 .
[17] Viswanath Devanarayan,et al. Recommendations for the validation of immunoassays used for detection of host antibodies against biotechnology products. , 2008, Journal of pharmaceutical and biomedical analysis.
[18] H. Lassmann,et al. APP peptides stimulate lymphocyte proliferation in normals, but not in patients with Alzheimer's Disease , 1996, Neurobiology of Aging.
[19] H. Koeppen,et al. Human plasma contains cross-reactive Abeta conformer-specific IgG antibodies. , 2008, Biochemistry.